Expertise in
21
conditions

Dr. Mitchell R. Kamrava

Radiation Oncology
Cedars-Sinai Radiation Oncology-Los Angeles
8720 Beverly Blvd, 
West Hollywood, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
21
conditions
Cedars-Sinai Radiation Oncology-Los Angeles
8720 Beverly Blvd, 
West Hollywood, CA 

Overview

Mitchell Kamrava is a Radiation Oncologist practicing medicine in West Hollywood, California.

Dr. Kamrava is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Vaginal Cancer, Prostate Cancer, Prostatectomy, and Vitrectomy.

He is actively involved in clinical research, co-authoring 180 peer reviewed articles and participating in 7 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in CA

Hospital Affiliations

Ronald Reagan UCLA Medical Center
Cedars-Sinai Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Cedars-Sinai Radiation Oncology-Los Angeles
8720 Beverly Blvd, West Hollywood, CA 90048

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Enrollment Status: Recruiting
Publish Date: March 10, 2026
Intervention Type: Procedure, Other, Radiation
Study Phase: Not Applicable
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer
Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2026
Intervention Type: Drug, Radiation
Study Drug: pembrolizumab
Study Phase: Phase 1/Phase 2
IIT2021-07-Atkins-CARMA: Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
IIT2021-07-Atkins-CARMA: Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Other
Study Phase: Not Applicable
GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer
GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer
Enrollment Status: Terminated
Publish Date: May 21, 2024
Intervention Type: Drug
Study Drug: Drug GC4711
Study Phase: Phase 2
Feasibility of Repeat Targeted Biopsies in Patients Undergoing High-Dose-Rate Prostate Brachytherapy
Feasibility of Repeat Targeted Biopsies in Patients Undergoing High-Dose-Rate Prostate Brachytherapy
Enrollment Status: Withdrawn
Publish Date: July 24, 2020
Intervention Type: Other, Procedure
Study Phase: Not Applicable
View 5 Less Clinical Trials

180 Total Publications

GLP-1 Receptor Agonists and Cardiovascular Events During Androgen Receptor Pathway Inhibitor Therapy.
GLP-1 Receptor Agonists and Cardiovascular Events During Androgen Receptor Pathway Inhibitor Therapy.
Journal: medRxiv : the preprint server for health sciences
Published: June 12, 2026
Similar Doctors
Expertise in
10
conditions
Dr. Leslie K. Ballas
Radiation Oncology
Expertise in
10
conditions
Dr. Leslie K. Ballas
Radiation Oncology
Referral may be required

Cedars-Sinai Radiation Oncology-Los Angeles

8720 Beverly Blvd, 
West Hollywood, CA 
 (0.1 miles away)
310-423-4208
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leslie Ballas is a Radiation Oncologist practicing medicine in West Hollywood, California. Dr. Ballas is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Bladder Reconstruction, and Prostatectomy.

Expertise in
35
conditions
Dr. Tania B. Kaprealian
Radiation Oncology
Expertise in
35
conditions
Dr. Tania B. Kaprealian
Radiation Oncology
Referral may be required

Office

200 Medical Plz, 
Los Angeles, CA 
 (3.8 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tania Kaprealian is a Radiation Oncologist practicing medicine in Los Angeles, California. Dr. Kaprealian is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses Meningioma, Radiation Induced Meningioma, Metastatic Brain Tumor, Schwannoma, and Thalamotomy.

Expertise in
32
conditions
Dr. Arya R. Amini
Radiation Oncology
Expertise in
32
conditions
Dr. Arya R. Amini
Radiation Oncology
Referral may be required

Arya Amini, M.D.

1500 Duarte Rd, 
Duarte, CA 
 (23.7 miles away)
800-826-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arya Amini is a Radiation Oncologist practicing medicine in Duarte, California. Dr. Amini is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Glossectomy, and Penectomy.

Frequently Asked Questions about Dr. Mitchell R. Kamrava

How do I make an appointment with Dr. Mitchell R. Kamrava?

You can book an appointment with Dr. Mitchell R. Kamrava by calling their office at 310-423-4208. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mitchell R. Kamrava a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mitchell R. Kamrava is classified as an Elite expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mitchell R. Kamrava specialize in?

While Dr. Mitchell R. Kamrava is a Radiation Oncology, they have specific expertise in Cervical Cancer, Vaginal Cancer, and Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mitchell R. Kamrava participate in research or clinical trials?

Yes. Dr. Mitchell R. Kamrava has published 180 articles and abstracts on conditions like Cervical Cancer. You can view a list of Dr. Mitchell R. Kamrava's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mitchell R. Kamrava accept my insurance?

Dr. Mitchell R. Kamrava accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-423-4208 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kamrava's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 12 Advanced Conditions
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile